Literature DB >> 25403997

Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.

Philipp Schommers1, Marcus Hentrich, Christian Hoffmann, Daniel Gillor, Alexander Zoufaly, Björn Jensen, Johannes R Bogner, Jan Thoden, Jan-Christian Wasmuth, Timo Wolf, Mark Oette, Markus Müller, Stefan Esser, Jörg J Vehreschild, Gerd Fätkenheuer, Christoph Wyen.   

Abstract

Overall survival (OS) of patients with acquired immunodeficiency syndrome (AIDS)-related Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and plasmablastic lymphoma (PBL) was analysed in the German AIDS-related-Lymphoma-Cohort-Study. Of 291 patients prospectively included between January 2005 and December 2012, 154 had DLBCL, 103 BL and 34 PBL. Two-year OS rates were similar between BL (69%) and DLBCL patients (63%) but lower for PBL patients (43%). Intermediate (Hazard ratio [HR] 4·1 95% confidence interval [CI] 1·98-8·49) or high (HR 4·92 95% CI 2·1-11·61) International Prognostic Index, bone marrow involvement (HR 1·69 95% CI 1·00-2·84) and PBL histology (HR 2·24 95% CI 1·24-4·03) were independent predictors of mortality.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  AIDS-related Burkitt lymphoma; AIDS-related diffuse large B-cell-lymphoma; AIDS-related lymphoma; AIDS-related plasmablastic lymphoma; lymphoma

Mesh：

Year:  2014        PMID： 25403997     DOI： 10.1111/bjh.13221

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  15 in total

1.  Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Authors:  Ariela Noy; Shelly Y Lensing; Page C Moore; Neel Gupta; David Aboulafia; Richard Ambinder; Robert Baiocchi; Bruce J Dezube; David Henry; Lawrence Kaplan; Alexandra M Levine; Ronald Mitsuyasu; Lee Ratner; Erin Reid; Scot Remick; Joseph Sparano; Dimitrios Tzachanis; William Wachsman; Amy Chadburn
Journal:  Leuk Lymphoma       Date:  2015-12-16

2.  Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study.

Authors:  Jiazhu Wu; Yi Miao; Chuan Qian; Pengfei Tao; Xicheng Wang; Xingqi Dong; Xia Li; Jincheng Lou; Jinhua Liang; Wei Xu; Jianyong Li; Haiyan Min
Journal:  J Cancer       Date:  2021-03-15       Impact factor: 4.207

3.  Plasmablastic Lymphoma: Case Report of Prolonged Survival of an Advanced Human Immunodeficiency Patient and Literature Review.

Authors:  Hind Rafei; Ehab El-Bahesh; Antoine Finianos; Min-Ling L Liu; Geraldine P Schechter
Journal:  Case Rep Hematol       Date:  2017-09-24

4.  HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006-2013.

Authors:  Lin Chen; Xiaohong Pan; Qiaoqin Ma; Jiezhe Yang; Yun Xu; Jinlei Zheng; Hui Wang; Xin Zhou; Tingting Jiang; Jun Jiang; Lin He; Jianmin Jiang
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

5.  Clinical Analysis of Five Cases of AIDS-related Non-Hodgkin Lymphoma.

Authors:  Shubo Zuo; Na Xu; Zhongkun Li; Na Li; Hong Xia; Hongtao Ren; Huizheng Bao
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

6.  Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.

Authors:  Philipp Schommers; Daniel Gillor; Marcus Hentrich; Christoph Wyen; Timo Wolf; Mark Oette; Alexander Zoufaly; Jan-Christian Wasmuth; Johannes R Bogner; Markus Müller; Stefan Esser; Alisa Schleicher; Björn Jensen; Albrecht Stoehr; Georg Behrens; Alexander Schultze; Jan Siehl; Jan Thoden; Ninon Taylor; Christian Hoffmann
Journal:  Haematologica       Date:  2018-02-08       Impact factor: 9.941

7.  Mortality risk in the population of HIV-positive individuals in Southern China: A cohort study.

Authors:  Zhigang Zheng; Jinying Lin; ZhenZhen Lu; Jinming Su; Jianjun Li; Guangjie Tan; Chongxing Zhou; Wenkui Geng
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

8.  HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.

Authors:  Juan Pablo Alderuccio; Adam J Olszewski; Andrew M Evens; Graham P Collins; Alexey V Danilov; Mark Bower; Deepa Jagadeesh; Catherine Zhu; Amy Sperling; Seo-Hyun Kim; Ryan Vaca; Catherine Wei; Suchitra Sundaram; Nishitha Reddy; Alessia Dalla Pria; Christopher D'Angelo; Umar Farooq; David A Bond; Stephanie Berg; Michael C Churnetski; Amandeep Godara; Nadia Khan; Yun Kyong Choi; Shireen Kassam; Maryam Yazdy; Emma Rabinovich; Frank A Post; Gaurav Varma; Reem Karmali; Madelyn Burkart; Peter Martin; Albert Ren; Ayushi Chauhan; Catherine Diefenbach; Allandria Straker-Edwards; Andreas Klein; Kristie A Blum; Kirsten Marie Boughan; Agrima Mian; Bradley M Haverkos; Victor M Orellana-Noia; Vaishalee P Kenkre; Adam Zayac; Seth M Maliske; Narendranath Epperla; Paolo Caimi; Scott E Smith; Manali Kamdar; Parameswaran Venugopal; Tatyana A Feldman; Daniel Rector; Stephen D Smith; Andrzej Stadnik; Craig A Portell; Yong Lin; Seema Naik; Silvia Montoto; Izidore S Lossos; Kate Cwynarski
Journal:  Blood Adv       Date:  2021-07-27

9.  Plasmablastic Lymphoma Mimicking Acute Pancreatitis.

Authors:  Faisal Inayat; Hafeez Ul Hassan Virk; Ahmad R Cheema; Muhammad Wasif Saif
Journal:  Case Rep Oncol Med       Date:  2016-03-13

10.  Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience.

Authors:  Luis Ernesto Cuellar; Andrea Anampa-Guzmán; Alexis Manuel Holguín; Juan Velarde; Diana Portillo-Alvarez; Marco Antonio Zuñiga-Ninaquispe; Esther Rosa Luna-Reyes; Jule Vásquez; Joanne Marie Jeter; Karen Marie Winkfield
Journal:  Infect Agent Cancer       Date:  2018-07-31       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.